Open Access 01-12-2018 | Letter
Feasibility, safety, and utility of bronchoscopy in patients with ARDS while in the prone position
Published in: Critical Care | Issue 1/2018
Login to get accessExcerpt
Prone positioning (PP) was shown to reduce mortality in mechanically ventilated (MV) patients with severe ARDS [1]. Despite its common use, safety concerns inhibit use of flexible bronchoscopy (FB) in patients with ARDS, and there are few reports of FB performed in PP [2]. We reviewed all adults receiving FB in PP in one institution between April 2016 and September 2017. The study was approved by the institutional review board. Four men and three women were identified (Table 1). In five patients, FB was indicated for clearance of thick secretions, and in two patients for microbial analysis. The mode of mechanical ventilation was not changed for FB, but FIO2 was universally set to 100%. All subjects had invasive hemodynamic and pulse oximetry monitoring. End-tidal carbon dioxide (EtCO2) was monitored in 3/7 subjects. With the subject’s head tilted to the side, the bronchoscope was advanced into the airways, repeatedly, and in short cycles, allowing time for oxygenation, ventilation, and lung recruitment between insertions. Therapeutic aspiration was performed in 6/7 subjects. Bronchoalveolar lavage was performed in two subjects. No significant hemodynamic compromise was observed during any of the procedures. Significant oxygen desaturation and rising EtCO2 were observed in one case (patient 4). Both derangements resolved with withdrawal of the bronchoscope and recruitment. No additional complications were documented. Figure 1 illustrates evolution of the PaO2:FIO2 ratio over time for each subject. Six subjects had antibiotics modified based on FB-obtained cultures. Consistent with previous data [3], 4/7 subjects survived 30 days following discharge from the ICU.
Table 1
Individual patient parameters, flexible bronchoscopy performance, and outcomes (n = 7)
Variable
|
Patient 1
|
Patient 2
|
Patient 3
|
Patient 4
|
Patient 5
|
Patient 6
|
Patient 7
|
---|---|---|---|---|---|---|---|
Age (years)
|
63
|
18
|
44
|
79
|
53
|
23
|
61
|
Sex
|
Female
|
Female
|
Male
|
Male
|
Male
|
Female
|
Male
|
Ethnicity
|
Black
|
Caucasian
|
Caucasian
|
Asian
|
Caucasian
|
Black
|
Caucasian
|
Etiology of ARDS
|
MRSA sepsis
|
Massive pulmonary embolism
|
Fulminant hepatic failure, Klebsiella sepsis
|
Pneumonia
|
Massive aspiration
|
Massive aspiration
|
Pneumonia
|
Total ICU LOS (days)/day of FB
|
27/9
|
30/13
|
97/32
|
35/29
|
9/2
|
49/11
|
16/1
|
Prone-positioning protocol (total hours)
|
28
|
18
|
16
|
236
|
20
|
133
|
18
|
30-day survival post ICU discharge
|
No
|
Yes
|
Yes
|
No
|
Yes
|
Yes
|
No
|
Ventilator-related parameters at FBa
|
|||||||
Mode
|
PRVC
|
PC/AC
|
VC/AC
|
PRVC
|
VC/AC
|
PC/AC
|
PC/AC
|
Peak pressure (cmH2O)
|
32
|
29
|
24
|
37
|
30
|
20
|
32
|
Plateau pressure (cmH2O)
|
27
|
NA
|
NA
|
30
|
26
|
NA
|
27
|
PEEP (cmH2O)
|
11
|
12
|
15
|
8
|
10
|
10
|
14
|
FIO2 (%)
|
100
|
100
|
100
|
100
|
100
|
100
|
100
|
FB-related data
|
|||||||
Δ-diameter ETT to bronchoscope (mm)
|
1.7
|
2.0
|
1.7
|
2.0
|
2.0
|
4.0
|
3.1
|
Therapeutic aspiration
|
Yes
|
Yes
|
Yes
|
No
|
Yes
|
Yes
|
Yes
|
Bronchial washings / BAL
|
Yes
|
Yes
|
Yes
|
Yes
|
Yes
|
Yes
|
Yes
|
Monitoring data
|
|||||||
MAP
|
|||||||
Baselinea
|
69
|
67
|
87
|
68
|
72
|
67
|
80
|
Trough during FB
|
69
|
64
|
72
|
66
|
71
|
67
|
68
|
SpO2
|
|||||||
Baselinea
|
94
|
98
|
97
|
100
|
100
|
100
|
100
|
Trough during FB
|
94
|
92
|
97
|
87
|
99
|
99
|
100
|
EtCO2
|
|||||||
Baselinea
|
48
|
30
|
NA
|
43
|
NA
|
NA
|
NA
|
Trough during FB
|
49
|
30
|
NA
|
51
|
NA
|
NA
|
NA
|
Change in antibiotic regimen based on culture results
|
De-escalation
|
De-escalation
|
No
|
Additional coverage
|
De-escalation
|
De-escalation
|
De-escalation
|
×
…